Literature DB >> 18317439

Are uremia, diabetes, and atherosclerosis linked with impaired antioxidant mechanisms?

Belda Dursun1, Evrim Dursun, Irfan Capraz, Tomris Ozben, Ali Apaydin, Gultekin Suleymanlar.   

Abstract

BACKGROUND: Oxidative stress is a new risk factor for atherosclerosis. Increased oxidative stress in hemodialysis (HD) patients may arise from uremia-associated metabolic/humoral abnormalities and bioincompatibility of dialysis. Patients with diabetes mellitus (DM) may be subject to an additional risk. Respective influences of uremia, diabetes, and HD duration in accelerated atherosclerosis and oxidative stress have not been clarified yet.
METHODS: The study was performed on 24 nondiabetic HD patients, 23 diabetic HD patients, 20 stages 3 to 4 chronic kidney disease patients, and 21 diabetic patients without overt nephropathy. Carotid intima-media thickness, a surrogate of atherosclerosis, was measured by high-resolution B-mode ultrasonography. Oxidant status was determined by lipid peroxidation as expressed by malondialdehyde (MDA); antioxidant status was determined by superoxide dismutase, catalase, glutathione peroxidase, reduced intracellular glutathione, and plasma thiol.
RESULTS: Intima-media thickness (IMT) was higher in patients undergoing HD but not different between nondiabetic HD patients and diabetic HD patients. No correlation was found between the duration of HD and intima-media thickness. Antioxidants were generally lower in HD patients. Intima-media thickness was positively correlated with MDA and negatively correlated with plasma thiol. Among other risk factors, only age was correlated with intima-media thickness.
CONCLUSIONS: Increased carotid IMT in HD patients is independent of duration of HD or diabetes status. Age and MDA are the significant predictors of carotid IMT. Increased oxidative stress due to impaired antioxidant mechanisms, particularly reduced plasma thiol redox potential, may account for accelerated atherosclerosis in high-risk patients with chronic kidney failure and/or DM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317439     DOI: 10.2310/JIM.0b013e3181641ce3

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  10 in total

Review 1.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

2.  Do GSTM1 and GSTT1 polymorphisms influence the risk of developing mitochondrial diseases in a Tunisian population?

Authors:  Raouia Ghorbel; Ghada Ben Salah; Rania Ghorbel; Afif Ben Mahmoud; Imen Chamkha; Emna Mkaouar-Rebai; Leila Ammar-Keskes; Faiza Fakhfakh
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-12       Impact factor: 4.223

3.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

4.  GSTO2*N142D gene polymorphism associated with hypothyroidism in Italian patients.

Authors:  Sara Piacentini; Paola Maria Monaci; Renato Polimanti; Dario Manfellotto; Maria Fuciarelli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

5.  Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation.

Authors:  Georgios Boudouris; Ioannis I Verginadis; Yannis V Simos; Andreas Zouridakis; Vasilios Ragos; Spyridon Ch Karkabounas; Angelos M Evangelou
Journal:  Int Urol Nephrol       Date:  2012-12-02       Impact factor: 2.370

6.  The assessment of oxidative stress on patients with chronic renal failure at different stages and on dialysis patients receiving different hypertensive treatment.

Authors:  Servin Yeşil Günal; Bilal Ustündağ; Ali İhsan Günal
Journal:  Indian J Clin Biochem       Date:  2013-03-26

7.  Levothyroxine replacement therapy with vitamin E supplementation prevents oxidative stress and cognitive deficit in experimental hypothyroidism.

Authors:  Tianrong Pan; Mingkui Zhong; Xing Zhong; Yanqing Zhang; Defa Zhu
Journal:  Endocrine       Date:  2012-09-23       Impact factor: 3.633

8.  Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparison of two dialysis membranes.

Authors:  H Ibrahim Varan; Belda Dursun; Evrim Dursun; Tomris Ozben; Gultekin Suleymanlar
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-04-12

Review 9.  Contribution of Brain Tissue Oxidative Damage in Hypothyroidism-associated Learning and Memory Impairments.

Authors:  Yousef Baghcheghi; Hossein Salmani; Farimah Beheshti; Mahmoud Hosseini
Journal:  Adv Biomed Res       Date:  2017-05-22

10.  gp91phox, a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism.

Authors:  Xiaochun Ma; Furong Wang; Xiaowen Zhen; Lifang Zhao; Li Fang; Zhenfang Dong; Wenbin Chen; Xiaoming Zhou
Journal:  Int J Endocrinol       Date:  2020-05-06       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.